Trials / Withdrawn
WithdrawnNCT01264510
Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha)
The Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha) in Patients With Conductive or Mixed Hearing Loss, or Unilateral Deafness
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A bone-anchored hearing aid (Baha) consists of a titanium implant located at the mastoid, and a sound processor connected with the implant. The sound processor delivers bone conducted stimuli to the cochlea, bypassing the outer and middle ear. Some patients who are unable to wear or do not benefit from a conventional air-conduction hearing aid, are candidate for a Baha. Typically, these patients suffer from a conductive or a mixed hearing loss. Recently however, Baha's are also being recommended in patients with unilateral deafness. Sound coming from the deaf side is captured and transmitted through bone conduction to the normal inner ear. The overall benefit of a Baha is more difficult to assess in those patients. Therefore, the goal of the current study is to examine the benefit of a Baha in patients with different audiological profiles (unilateral or bilateral conductive or mixed hearing loss, and unilateral deafness). Special attention will be given to predictive determinants of the benefit with a Baha, and to the improvement of pre-operative criteria and counseling of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | audiological test battery | routine audiological measurements. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2010-12-21
- Last updated
- 2022-12-29
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01264510. Inclusion in this directory is not an endorsement.